Vendor source
Reviewed 11 May 2026
Completeness Strong (72%)
Prostate Intelligence™
Lucida MedicalProstate Intelligence software intended to assist analysis of MRI for suspected prostate cancer. It uses a combination of image processing, deep learning and machine learning methods, to segment the prostate, identify regions of interest, and calculate risk scores.
Supported by 3 papers
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIb
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Concurrent AI-human interaction in prostate cancer MRI interpretation: More hype than help?
European Radiology Experimental · Mar 2026
AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study
European Radiology · Feb 2026
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study
European Radiology · Feb 2025
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Jun 6, 2024 | Last updated: May 11, 2026